Isoprenaline Infusion Dosing via Syringe Pump
For adults in shock, initiate isoprenaline at 0.5-5 mcg/min via continuous intravenous infusion, prepared by diluting 1 mg (5 mL) in 500 mL of 5% dextrose to yield a concentration of 2 mcg/mL. 1
Standard Adult Preparation and Dosing
- Dilute 1 mg of isoprenaline in 500 mL of 5% dextrose to create a concentration of 2 mcg/mL 1
- Start infusion at 0.5-5 mcg/min (0.25-2.5 mL/min of diluted solution) 1
- Concentrations up to 10 times greater (20 mcg/mL) may be used when volume restriction is essential 1
- In advanced shock states, rates exceeding 30 mcg/min have been utilized 1
Pediatric Dosing
For children, the American Heart Association recommends an initial infusion rate of 0.1 mcg/kg/min, with a usual therapeutic range of 0.1-1.0 mcg/kg/min. 1
- Begin at 0.1 mcg/kg/min and titrate based on clinical response 1
- The typical effective range spans 0.1-1.0 mcg/kg/min 1
Titration and Monitoring Parameters
Adjust infusion rate based on heart rate, central venous pressure, systemic blood pressure, and urine output. 1
- Decrease or temporarily discontinue if heart rate exceeds 110 beats per minute 1
- Monitor for cardiac arrhythmias and myocardial ischemia, particularly in patients with coronary artery disease or cardiomyopathy 1
- Titrate gradually upward from the lowest effective dose based on hemodynamic response 1
Critical Administration Considerations
- Inspect solution before use - discard if pinkish, darker than slightly yellow, or contains precipitate 1
- Use diluted solution immediately and discard any unused portion 1
- Isoprenaline contains sodium metabisulfite, which may cause allergic reactions including anaphylaxis in sulfite-sensitive patients 1
Important Contraindications
Do not use isoprenaline in patients with tachycardia, ventricular arrhythmias, or angina pectoris. 1
Drug Interactions to Avoid
- Never administer simultaneously with epinephrine - both are direct cardiac stimulants and combined use may induce serious arrhythmias 1
- Effects may be potentiated by tricyclic antidepressants, MAO inhibitors, levothyroxine, and certain antihistamines (chlorpheniramine, tripelennamine, diphenhydramine) - monitor hemodynamics closely and adjust doses accordingly 1
- Beta-blockers antagonize the cardiostimulating and bronchodilating effects of isoprenaline 1
Special Clinical Scenarios
For bronchospasm during anesthesia, administer as bolus injection rather than infusion: dilute 0.2 mg (1 mL) to 10 mL with normal saline or 5% dextrose, then give 10-20 mcg (0.5-1 mL of diluted solution) as initial dose, repeatable as needed 1
In Brugada syndrome with repetitive ventricular arrhythmias, a bolus of 1-2 mcg followed by continuous infusion at 0.15 mcg/min has been effective for suppressing arrhythmic storm 2